Environmental, Social And Governance (ESG) Report

Overview

The report is 3D Medicines Inc.'s first ESG report, covering the Group's sustainability practices and achievements in 2022. It describes a Board-led ESG management architecture, with the Board of Directors as the highest responsible and decision-making body. The report also records 245 regular employees and total GHG emissions of 3,746.82 tCO2e, comprising direct and indirect emissions.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services